⚰️Certification Requirements for Funeral Honors Providers
National Cemetery Administration, Department of Veterans Affairs (VA), is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act (PRA) of 1995, Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of a currently approved collection, and allow 60 days for public comment in response to the notice.
Learn More🐟NOAA Cancels SEDAR 98 Assessment Webinar for Gulf of America Red Snapper
The SEDAR 98 assessment process for Gulf of America red snapper will consist of a Data Workshop, a series of assessment webinars, and a Review Workshop. See SUPPLEMENTARY INFORMATION.
Learn More⚡Combined Notice of Electric Corporate Filings and Approvals
The document announces several electric corporate filings received by the Department of Energy and the Federal Energy Regulatory Commission. It includes joint applications for project authorizations, self-certification notices for exempt wholesale generators, and rate filings, along with deadlines for public comment and intervention procedures in ongoing proceedings.
Learn More⚡FERC Form No. 60 Filing Process Updates Announced
The Department of Energy and the Federal Energy Regulatory Commission announce updates to the FERC Form No. 60 filing process, restoring necessary XBRL taxonomies to Version 2024-04-01 and making it a requirement for the upcoming filing due on May 1, 2025. Changes regarding Version 2025-04-01 will be implemented for future filings.
Learn More⚛️NRC and Connecticut Agreement on Radioactive Material Regulations
As required by section 274e. of the Atomic Energy Act of 1954, as amended (AEA), the U.S. Nuclear Regulatory Commission (NRC or Commission) is publishing the proposed Agreement for public comment (Appendix A). The NRC is also publishing the summary of a draft assessment by the NRC staff of the State of Connecticut's regulatory program. Comments are requested on the proposed Agreement and its effect on public health and safety. Comments are also requested on the draft staff assessment, the adequacy of the State of Connecticut's program, and the adequacy of the staffing of the State's program, as discussed in this document.
Learn More💉FDA Updates on Susceptibility Test Interpretive Criteria Announced
The Food and Drug Administration (FDA, the Agency, or we) is announcing the availability of the Agency's annual compilation of notices of updates to the Agency's Susceptibility Test Interpretive Criteria web page. The Agency established the Susceptibility Test Interpretive Criteria web page on December 13, 2017, and since establishment has provided updates to both the format of the web pages and the susceptibility test interpretive criteria identified and recognized by FDA on the web pages. FDA is publishing this notice in accordance with procedures established by the 21st Century Cures Act (Cures Act).
Learn More📝OSC Annual Survey Notice and Public Comment Overview
The U.S. Office of Special Counsel is seeking approval from the Office of Management and Budget (OMB) for the reinstatement of an expired information collection request (ICR) under the Paperwork Reduction Act (PRA). OSC is statutorily required to conduct an annual survey assessing the effectiveness of its operations, including the handling of Prohibited Personnel Practice (PPP) complaints, whistleblower disclosures, and enforcement efforts. The collection gathers feedback from individuals who have sought OSC's assistance.
Learn More🔍Correction Notice on PBGC Asset Allocation Regulation
This document provides a correction to a prior publication regarding the allocation of assets in single-employer plans by the Pension Benefit Guaranty Corporation. It specifically addresses an editorial error in the supplementary information section of the rule, ensuring clarity in the regulatory text related to benefit valuation assumptions.
Learn More🚫FDA Withdraws Approval for 18 New Drug Applications
The Food and Drug Administration (FDA or Agency) is withdrawing approval of 18 new drug applications (NDAs) from multiple applicants. The applicants notified the Agency in writing that the drug products were no longer marketed and requested that the approval of the applications be withdrawn.
Learn More📊FDA Seeks Comments on Electronic Study Data Submission Standards
The Food and Drug Administration (FDA or Agency) is exploring Clinical Data Interchange Standards Consortium (CDISC) Dataset- JavaScript Object Notation (Dataset-JSON) version 1.1 as a new exchange standard, with the long-term potential to replace Statistical Analysis System (SAS) version 5 XPORT Transport Format (XPT), for submission of electronic study data to the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER). FDA is requesting comments on whether to accept Dataset-JSON to exchange electronic study data as part of regulatory applications in the future. In particular, FDA is requesting feedback on the risks and benefits of industry adopting Dataset-JSON as a new exchange standard for submitting electronic study data to FDA and any integration challenges with existing tools and systems.
Learn More